v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net income (loss) $ (953,000) $ 122,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Debt discount amortization 5,000 (0)
Change in fair value of derivative liability (20,000) 0
Fair value of common stock issued for services 244,000 0
Fair value of warrants granted for services 0 195,000
Gain on patent assignment 0 (880,000)
Effect of changes in:    
Accounts receivable 6,000 (122,000)
Prepaid expenses 20,000 5,000
Operating lease right of use asset 0 42,000
Accounts payable and accrued expenses 171,000 12,000
Accrued payroll and payroll taxes – related parties 0 48,000
Operating lease liability 0 (46,000)
Net cash used in operating activities (527,000) (624,000)
Investing activities:    
Proceeds from patent assignment 0 880,000
Net cash provided by investing activities 0 880,000
Financing activities:    
Proceeds from convertible note payable 60,000 0
Proceeds from common stock units 173,000 0
Proceeds from note payable 90,000 0
Repayment of note payable 0 (3,000)
Net cash provided by (used in) financing activities 323,000 (3,000)
Net (decrease) increase in cash and cash equivalents (204,000) 253,000
Cash and cash equivalents, beginning of period 249,000 179,000
Cash and cash equivalents, end of period 45,000 432,000
Supplemental disclosures of cash flow information:    
Cash paid for interest 3,000 5,000
Cash paid for income taxes 0 0
Supplemental disclosures of non-cash transactions:    
Conversion feature of convertible notes payable accounted as derivative liability 38,000 0
Fair value of common stock and warrants granted to settle accrued payroll and payroll taxes - related parties $ 0 $ 462,000